L 163958
an angiotensin II receptor antagonist; has equal affinity for type 1 and type 2 receptors, structure given in first source
Also Known As:
2-(2-bromo-5-valerylamino)-4-((2'-(N-(tert-butyloxycarbonyl)sulfamoyl)-3-fluorobiphenyl-4-yl)methyl)-2,4-dihydro-5-ethyl-3H-1,2,4-triazol-3-one; L 163,958; L-163,958; L-163958
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results